4
Changes in Ownership
MYRIAD GENETICS INC Filed Acc 0001219036-21-000014
Chief Scientific Officer sold 32,308 shares at an average $32.27 ($1,042,660)
- Chief Scientific Officer acquired 32,308 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LANCHBURY JERRY S · Chief Scientific Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-07 | Exercise or conversion : show line 1 in the form | +30,424 | $26.49 | $805,932 | 262,974 | D |
| 2021-07-07 | Sale : show line 2 in the form | −30,424 | $32.29 | $982,391 | 232,550 | D |
| 2021-07-07 | Exercise or conversion : show line 3 in the form | +1,884 | $26.49 | $49,907 | 234,434 | D |
| 2021-07-07 | Sale : show line 4 in the form | −1,884 | $31.99 | $60,269 | 232,550 | D |
| Open-market sales · 32,308 sh · avg $32.27 · $1,042,660 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-07-07 | Exercise or conversion : show line 5 in the form Incentive Stock Option (right to buy) | −1,884 | 0 | D |
| 2021-07-07 | Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) | −30,424 | 141,828 | D |
Loading xslF345X03/edgardoc.xml…